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Introduction
Cell proliferation is a key phenomenon during development and   
repair. It is regulated by complex extrinsic and intrinsic mecha­
nisms involving Cdks, a family of serine/threonine kinases that 
represents the core of the cell cycle machinery. Successive waves 
of Cdk activity control initiation and progression through the 
eukaryotic cell cycle in response to both intracellular and extra­
cellular signals. During G1 phase, phosphorylation of the retino­
blastoma protein (Rb) by Cdk4/6 and Cdk2—activated upon 
specific binding of the D and E cyclins, respectively (Morgan, 
1997)—promotes transcription of genes essential for S phase 
entry. Activity of Cdk2/cyclin E complexes is thought to irre­
versibly phosphorylate Rb proteins to promote G1/S transition.
Despite the fundamental role of Cdks in cell cycle pro­
gression, recent data demonstrated molecular redundancies in 
their function, as single targeted disruption of mouse Cdk2, Cdk4, 
or Cdk6 genes did not result in lethality, nor in defects in or­
ganogenesis (Rane et al., 1999; Tsutsui et al., 1999; Berthet et al., 
2003; Ortega et al., 2003; Malumbres et al., 2004). However, 
inactivation of genes encoding individual Cdks affects cell divi­
sion in specific cell types (Rane et al., 1999; Tsutsui et al., 1999; 
Moons et al., 2002; Malumbres et al., 2004; Atanasoski et al., 
2008; Lange et al., 2009). In spite of its crucial role in the cell 
cycle, and probably because of redundancies with other Cdks, 
Cdk2 was shown to be dispensable during embryonic develop­
ment, as Cdk2­null mice are viable, but indispensable in specific 
cell types, as Cdk2­null mice are sterile (Berthet et al., 2003).
In the central nervous system (CNS), proliferation of oligo­
dendrocyte progenitor cells (OPCs) is crucial for effective 
myelination and remyelination. Indeed, during development, the 
majority of OPCs undergo a limited period of proliferation,   
before cell cycle exit and terminal differentiation into myelin­
ating oligodendrocytes (Temple and Raff, 1986). However, a   
T
he specific functions of intrinsic regulators of oligo-
dendrocyte progenitor cell (OPC) division are poorly 
understood. Type 2 cyclin-dependent kinase (Cdk2) 
controls cell cycle progression of OPCs, but whether it acts 
during myelination and repair of demyelinating lesions 
remains unexplored. Here, we took advantage of a viable 
Cdk2
/ mutant mouse to investigate the function of this 
cell cycle regulator in OPC proliferation and differentia-
tion in normal and pathological conditions. During central 
nervous system (CNS) development, Cdk2 loss does not 
affect OPC cell cycle, oligodendrocyte cell numbers, or 
myelination. However, in response to CNS demyelination, 
it clearly alters adult OPC renewal, cell cycle exit, and   
differentiation.  Importantly,  Cdk2  loss  accelerates  CNS   
remyelination of demyelinated axons. Thus, Cdk2 is dis-
pensable for myelination but is important for adult OPC 
renewal, and could be one of the underlying mechanisms 
that drive adult progenitors to differentiate and thus re-
generate myelin.
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competent  cells.  Thus,  these  developmental­repair  processes   
appear to be ideal events to investigate the requirements for 
Cdk2  in  NPC/OPC  cell  cycle  regulation. Although  previous 
studies showed that Cdk2 controls cell cycle progression of 
neonatal OPCs in vitro (Belachew et al., 2002), and prolifera­
tion and self­renewal of adult NPCs (Jablonska et al., 2007), the 
role of this Cdk in NPC/OPC cell cycle regulation in pathologi­
cal conditions has not yet been investigated.
In the present study, we have used Cdk2 knockout (KO) 
mice to investigate the role of Cdk2 in adult OPC and NPC pro­
liferation and differentiation in vivo, and to demonstrate its im­
plication in oligodendrocyte regeneration and remyelination in 
the white matter under pathological conditions. Because myelin 
is essential for axonal conduction, neuroprotection, and fine­
tuning of brain signals during neural development and brain re­
pair (Fields, 2008), our study defines an important molecular 
mechanism that regulates a crucial regenerative process in the 
mammalian brain.
Results
Cdk2 loss alters neither OPC proliferation 
nor developmental myelination in the 
postnatal and adult corpus callosum
Cdk2 is considered a key regulator of S phase entry and a cru­
cial mediator of OPC cell cycle progression in vitro (Belachew   
et al., 2002). To identify a possible requirement of Cdk2 in divid­
ing cells of the corpus callosum (CC) in vivo, we first quantified 
the total number of proliferating Ki67
+ cells at P8 and P90. As 
described previously (Belachew et al., 2002), we observed a dra­
matic developmental reduction (>90%) of the number of Ki67
+ 
cells between P8 and P90 (Fig. 1 B and Fig. S2 B), but no sig­
nificant difference was detected between genotypes (wild type 
[WT] vs. Cdk2
/; Fig. 1 B and Fig. S2 B). Double immuno­
histochemistry for NG2, a marker of OPCs, and Ki67 confirmed 
previously observed differences in proliferation of NG2
+ cells 
in the adult anterior SVZ and in the rostral migratory stream 
(Fig. S2 C; Jablonska et al., 2007). However, no alteration in the 
proliferating fraction of NG2
+ cells at P8 (Fig. 1, A and C) or at 
P90 (Fig. S2 C) was observed in the CC of mutant versus control 
animals. These results suggest that, in vivo, OPC proliferation 
in the CC during early postnatal and adult stages is either Cdk2 
independent or efficiently compensated by other Cdks.
Throughout early postnatal and adult life, white matter 
oligodendrocytes derive from OPCs that undergo a series of 
developmental changes before acquiring a mature phenotype 
(Pfeiffer et al., 1993). Specific markers characterize consecutive 
stages of oligodendrocyte maturation. Among various markers, 
NG2 labels OPCs and CC1 is a marker of postmitotic oligo­
dendrocytes; conversely, Olig2 is expressed through the entire 
oligodendroglial lineage (Zhou et al., 2000). Given that OPC 
proliferation was not altered in Cdk2
/ mice, we observed no 
change in the densities of the different oligodendrocyte popula­
tions in WT versus Cdk2
/ mice at any developmental stage 
examined (Fig. S1).
We demonstrated that Cdk2 loss does not affect the num­
ber of oligodendrocytes and OPCs or their proliferation rate. 
population  of  slowly  dividing  OPCs  persists  throughout  the 
adult CNS (Ffrench­Constant and Raff, 1986; Wolswijk and 
Noble, 1989; Reynolds and Hardy, 1997). Despite their low oligo­
dendrogenic potential under physiological conditions, adult 
OPCs are responsible for remyelination after white matter in­
sults (Wolswijk and Noble, 1989; Gensert and Goldman, 1997; 
Chang et al., 2000; Franklin, 2002). OPCs can also be gener­
ated by neural precursor cells (NPCs) of the subventricular zone 
(SVZ) in the adult forebrain both under physiological conditions 
(Levison and Goldman, 1993; Doetsch et al., 1999) and after de­
myelination in rodents and human brain (Nait­Oumesmar et al., 
1999; Picard­Riera et al., 2002; Nait­Oumesmar et al., 2007). 
After demyelination of the adult brain, SVZ­derived OPCs are 
recruited to the lesions and contribute to remyelination (Menn 
et al., 2006; Aguirre et al., 2007).
CNS  myelination  and  remyelination  result  from  co­
ordinated spatio­temporal events involving OPC proliferation, 
migration/recruitment, and differentiation into functional myelin­
Figure 1.  OPC proliferation and postnatal myelination in Cdk2
/ mice. 
(A) Coronal section of the CC area from P8 WT mice immunostained 
for NG2 and Ki67. Inset (enlarged view of the boxed region) identifies   
double-labeled cells. Bar, 50 µm. (B) Histogram comparing the overall density 
of Ki67
+ cells in the CC at P8 in WT versus Cdk2
/ mice. (C) Histogram 
comparing the proliferative rate of NG2-expressing OPCs at P8 in WT 
versus Cdk2
/ mice. (D and E) Images of the CC were taken by electron 
microscopy from ultrathin sections of WT (D) and Cdk2
/ (E) P15 mice. 
The myelin sheath is represented at a higher magnification in the inset. 
Bar, 2 µm. (F) Histogram representing the number of myelinated axons in 
the CC. (G) Histogram representing g ratio in WT versus Cdk2
/ mice.   
(H and I) Western blot analysis of MBP quantity in WT versus Cdk2
/ 
mice. Actin was used as a loading control. Results are expressed as means ± 
SEM (error bars) and were analyzed by a t test.399 Role of Cdk2 in OPC proliferation • Caillava et al.
results were analyzed with a t test). Although the loss of Cdk2 
had no effect on proliferation in the CC of nonlesioned mice 
(Fig. S2B), we found that the number of proliferative Ki67
+ 
cells in the lesion was significantly decreased in Cdk2
/ mu­
tants, as compared with WT mice (Fig. 2, C and D). These re­
sults were also confirmed by evaluating cell proliferation using 
BrdU incorporation, which identifies cells progressing through 
S phase (Fig. S3).
Because the decrease in proliferation observed in different 
structures of Cdk2
/ brains could be caused by an increase in 
cell death in response to demyelination, we also investigated the 
potential contribution of apoptosis. TUNEL
+ cells were quanti­
fied in different brain regions (ASVZ/RMS, CC, and lesion)   
after LPC demyelination. No significant difference was ob­
served in the rate of cell death between Cdk2
/ and WT mice 
(Fig. S4).
Finally, we also compared cell cycle exit of Olig2
+ oligo­
dendroglial lineage cells in Cdk2
/ versus WT mice. BrdU 
was injected 15 h before sacrifice. As BrdU labels a cohort of 
cells in S phase, and Ki67 labels proliferating cells throughout 
all  phases  of  the  cell  cycle,  double­immunoreactive  BrdU
+/
Ki67
+ cells measured the proportion of cycling cells, whereas 
the  remaining  BrdU
+/Ki67
  cells  indicated  cells  that  exited 
from the cell cycle. The cell cycle exit index of Olig2
+ cells 
(number of Olig2
+/BrdU
+/Ki67
 cells divided by the total popu­
lation of Olig2
+/BrdU
+ cells) showed that loss of Cdk2 caused a 
significant increase in Olig2
+ cell cycle exit in both the SVZ and 
the demyelinated lesion (Fig. 3).
However, as in the CNS oligodendrocytes are responsible for 
myelin sheath synthesis, with each cell myelinating up to 40 in­
dependent axonal segments (Matthews and Duncan, 1971), loss 
of Cdk2 could impact myelin synthesis. To investigate this pos­
sibility, we used electron microscopy to quantify numbers of 
myelinated axons in the CC at postnatal day 15 (P15), a period 
of active myelination in rodents. We did not observe any differ­
ence in the numbers of myelinated axons in the CC between 
WT and Cdk2
/ mice (Fig. 1, D–F). In addition, Western blot 
quantification of myelin basic protein (MBP), one of the most 
abundant CNS myelin protein (Boggs, 2006), showed no differ­
ence in its level between the two genotypes (Fig. 1, H and I). 
Despite these findings, we questioned whether loss of Cdk2 
could impact myelin sheath structure. High­magnification ultra­
structural analysis showed that myelin sheath appearance was 
normal in the absence of Cdk2 (Fig. 1, D and E, insets). Further­
more, g ratio assessment indicated similar myelin thickness in 
Cdk2
/ and WT mice (Fig. 1 G). Finally, no differences in the 
parameters described above were observed between Cdk2
/ 
and WT mice at later stages of the myelination process in the 
adult brain (P90; Fig. S2, D–I). We also confirmed that the total 
number of axons was not significantly different between the two 
genotypes  (WT,  991,128  ±  44,190  axons/mm
2;  Cdk2
/, 
914,113 ± 26,150 axons/mm
2; P = 0.14; results were analyzed 
with a t test).
Loss of Cdk2 attenuates cell proliferation 
in response to demyelination in the  
adult brain
Demyelination of the CC is known to increase proliferation 
of  NPCs  in  the  adult  SVZ  (Nait­Oumesmar  et  al.,  1999; 
Decker et al., 2002). Thus, we investigated the role of Cdk2 
in cell proliferation in the adult anterior SVZ (ASVZ), where 
stem cells and neural progenitors proliferate, and in the ros­
tral migratory stream (RMS), where cells migrate toward the 
olfactory  bulb.  We  compared  proliferation  in  adult  (P90) 
Cdk2
/ and WT mice in response to demyelination. Adult 
mice were injected with lysolecithin (LPC) to induce focal 
demyelination in the rostral CC (Fig. S3 D) and were sacri­
ficed 7 d postinjection (dpi). In this well­established animal 
model (Nait­Oumesmar et al., 1999; Woodruff and Franklin, 
1999; Watanabe et al., 2002), demyelination is accomplished 
within 2 d after toxin injection, and a proliferative cellular 
response is observed in both the ASVZ/RMS and the lesion 
(Nait­Oumesmar  et  al.,  1999)  during  the  first  week  after   
LPC injection.
We first quantified the rate of cell proliferation in response 
to demyelination by using Ki67 immunostaining, and found 
that, as previously demonstrated in the absence of demyelin­
ation (Fig. S2 C; Jablonska et al., 2007), the absence of Cdk2 
induced a significant decrease in the total number of prolifer­
ating cells of the ASVZ and RMS (Fig. 2, A, B, and D). We 
next evaluated whether Cdk2 influences OPC proliferation in 
the demyelinated lesion. At 7 dpi, the lesion area was defined by 
the absence of MBP labeling. No difference in lesion size could 
be found between Cdk2
/ and WT animals (WT, 0.58 ± 0.09 
mm
2 of demyelinated area; Cdk2
/, 0.49 ± 0.08 mm
2; P = 0.46; 
Figure  2.  Cell  proliferation  in  response  to  demyelination  in  the  adult 
brain. (A–C) 7 dpi, proliferating cells were labeled with anti-Ki67 in the 
ASVZ (A), the RMS (B), and in the demyelinated lesion (C) of WT (A1–C1) 
and Cdk2
/ P90 mice (A2–C2). Broken lines delineate the different re-
gions. cc, corpus callosum; str, striatum; lv, lateral ventricle. Bar, 50 µm. 
(D) Histogram representing the number of Ki67 labeled cells per surface in 
each region. Results are expressed as means ± SEM (error bars; *, P < 0.05; 
**, P < 0.001) and were analyzed by a t test.JCB • VOLUME 193 • NUMBER 2 • 2011   400
Cdk2 loss affects proliferation of  
specific ASVZ cell types in response  
to demyelination
In the adult SVZ, slowly dividing stem cells (type B cells) ex­
pressing glial fibrillary acidic protein (GFAP) and nestin give 
rise to highly proliferative transient­amplifying cells (type C cells), 
which express Mash1, Dlx2, and/or Olig2. These cells differ­
entiate into migrating neuroblasts (type A cells) expressing the 
polysialylated acidic form of the neural cell adhesion molecule 
(PSA­NCAM), class III ­tubulin (Tuj1), or doublecortin (Dcx; 
Doetsch et al., 2002). Type B cells also generate other SVZ pro­
genitors expressing NG2, which are highly proliferative type 
C–like cells and give rise mainly to oligodendrocytes (Nishiyama, 
1998; Aguirre et al., 2004; Cerghet et al., 2006; Nishiyama, 
2007). To identify which cell population of the ASVZ was mostly 
affected by the loss of Cdk2 in response to demyelination, we 
performed immunohistochemical analysis at 7 dpi using the 
proliferation marker Ki67 and BrdU, in combination with spe­
cific markers of each cell type (Fig. 4 and Fig. S5). Quantifi­
cation of double­labeled cells showed that Cdk2 loss had no 
effect on the proliferative potential of GFAP
+ cells in response 
to demyelination (Fig. S5 A). This is consistent with the very 
low rate of proliferation of these stem cells, and previous re­
sults obtained in normal, nondemyelinated brains (Jablonska   
et al., 2007). Proliferation of PSA­NCAM
+ cells was also un­
affected by Cdk2 loss (Fig. S5 B). However, Cdk2 loss induced 
a significant twofold decrease in the proliferation rate of cells 
giving rise to oligodendrocytes in response to demyelination, 
Figure 3.  Cell cycle exit in response to demyelination in the adult brain. (A and B) 7 d after LPC injection, cells were labeled with anti-Olig2, anti-BrdU, and 
anti-Ki67 in the ASVZ (A) and in the demyelinated lesion (B) of WT (A1–B1) and Cdk2
/ P90 mice (A2–B2). As BrdU was injected 15 h before sacrifice, 
triple-immunoreactive Olig2
+/BrdU
+/Ki67
+ cells measured the proportion of Olig2
+ cycling cells while the remaining Olig2
+/BrdU
+/Ki67
 cells indicated 
Olig2
+ cells that exited from the cell cycle. Broken lines delineate the different regions. Arrowheads point to double-labeled cells Olig2
+/BrdU
+/Ki67
.   
cc, corpus callosum; str, striatum; lv, lateral ventricle. Bar, 50 µm. (C) Histogram representing the cell cycle exit index of Olig2
+ cells calculated by dividing 
the number of Olig2
+/BrdU
+/Ki67
 cells by the total population of Olig2
+/BrdU
+ cells. Results are expressed as means ± SEM (error bars; **, P < 0.001) 
and were analyzed by a t test.
including NG2
+, Olig2
+, and Mash1
+ cells (Fig. 4, A, B, and C; 
Gensert and Goldman, 1997; Watanabe et al., 2002; Menn et al., 
2006; Parras et al., 2007).
Loss of Cdk2 specifically affects 
oligodendrocyte proliferation in LPC lesions
Multiple cell types proliferate in response to LPC­induced 
demyelination, particularly astrocytes and oligodendrocytes. 
Furthermore, although the immune response is reduced in the 
LPC focal demyelination model, as compared with experimen­
tal autoimmune encephalomyelitis, microglia/macrophages still 
play a major role in eliminating myelin fragments. To examine 
the consequence of Cdk2 loss in proliferation on various glial 
cell populations after demyelination, we performed immuno­
histochemical analysis using the proliferation marker Ki67 
in combination with specific cellular markers (Fig. 5). In the   
lesion, loss of Cdk2 did not affect proliferation of CD45
+ cells, 
a general marker for immune cells or GFAP
+ astrocytes (Fig. 5, 
A and B). However, the absence of Cdk2 specifically altered 
oligodendrocyte proliferation, as proliferation of the Olig2
+ oligo­
dendroglial population (Fig. 5 C) and of the NG2
+ OPC pool 
(Fig. 5 D) were both significantly decreased when compared 
with WT littermates at 7 dpi. To better define the dynamics of 
OPC proliferation, we also analyzed proliferation of these cells 
at 14 dpi. As predicted from the well­defined profile of cellu­
lar dynamics during demyelination and remyelination in LPC 
lesions (Nait­Oumesmar et al., 1999; Woodruff and Franklin, 
1999; Watanabe et al., 2002; Aguirre et al., 2007), we observed 401 Role of Cdk2 in OPC proliferation • Caillava et al.
To better define the dynamics of oligodendroglial differ­
entiation in the lesion, the same cell markers were also analyzed 
21 dpi, i.e., when the population of oligodendrocytes is likely to 
have matured. In the absence of Cdk2, the density of Olig2
+ cells 
and NG2
+ cells remained lower than in WT (Fig. 6 F). However, 
the density of CC1
+ cells was similar in Cdk2
/ and WT mice. 
These results suggest that, in the absence of Cdk2, the rate of 
oligodendrocyte differentiation was accelerated during the pro­
cess of remyelination, but the delay of differentiation observed 
in WT compared with Cdk2
/ mice recovered with time.
Accelerated differentiation of adult OPCs in the absence 
of  Cdk2  was  further  analyzed  in  OPCs  purified  from  adult 
Cdk2
/ and WT mice grown for 5 d in vitro. Immunohisto­
chemistry for A2B5 (a marker for OPCs) and O4 (a marker of 
preoligodendrocytes) showed that, after 5 d in vitro, the number of 
immature A2B5
+ cells was reduced threefold in Cdk2
/ oligo­
dendroglial cultures, as compared with WT cells (Fig. 7, A,   
B, and E). In contrast, the number of O4
+ preoligodendrocytes 
was significantly increased, and these cells displayed a more 
branched morphology in the absence of Cdk2, as compared with 
controls (Fig. 7, C–F), although the initial number of O4
+ cells 
(5 h after plating) was identical (WT, 8 ± 1%; Cdk2
/, 13 ± 2%; 
P = 0.14, results were analyzed with a t test). Similar data were 
also obtained for GalC
+ cells.
Remyelination is accelerated in the lesions 
of Cdk2 KO mice
We further investigated if the accelerated oligodendrocyte dif­
ferentiation observed in the absence of Cdk2 had an impact on 
remyelination. Electron microscopy analysis of ultrathin sec­
tions was used to precisely quantify the number of myelinated 
a high rate OPC proliferation in WT mice in response to demye­
lination at 7 dpi, followed by a decrease at 14 dpi corresponding 
to the differentiation phase (Fig. 5 D). Interestingly, Cdk2
/ 
OPC proliferation remained at steady levels at 14 dpi compared 
with 7 dpi (Fig. 5 D), which suggests that Cdk2
/ OPCs are 
less responsive to the lesion­induced signals of proliferation.
Oligodendrocyte maturation is accelerated 
in the absence of Cdk2
In CC, two sources of cells are likely to contribute to endog­
enous remyelination: the resident white matter adult OPCs and 
stem/precursor cells migrating from the adult SVZ (Gensert 
and Goldman, 1997; Nait­Oumesmar et al., 1999; Picard­Riera 
et al., 2002; Watanabe et al., 2002; Menn et al., 2006; Aguirre 
et al., 2007). Given the effect of Cdk2 loss on OPC proliferation 
in these two areas, we also investigated its impact on oligoden­
drocyte differentiation in the lesion. In rodents, spontaneous re­
myelination begins at 7 dpi and proceeds to be completed after 
28 dpi. At 7 dpi, the density of Olig2
+ cells in the lesion was 
similar in Cdk2
/ and WT animals, and resulted from a slightly 
higher density of CC1
+ cells and a reduced density of NG2
+ 
cells (Fig. 6 D) in Cdk2
/ mice, as compared with WT, which 
indicates a decreased number of immature cells in Cdk2
/. At 
14 dpi, both the density of Olig2
+ cells and the density of NG2
+ 
OPCs in the lesion were reduced in Cdk2
/ mice, as compared 
with WT (Fig. 6, A, C, and E). However, the density of CC1
+ 
cells was significantly increased in the lesion of Cdk2
/ mice 
(Fig. 6, B and E) compared with WT, which indicates enhanced 
differentiation of immature OPCs to mature oligodendrocytes. 
These findings were consistent with the lower proliferation rate 
of these cell populations in the Cdk2
/ mouse.
Figure  4.  Characterization  of  adult  ASVZ 
cells in which proliferation is affected by the 
loss of Cdk2 in response to demyelination. 
Characterization of proliferating cells in the 
ASVZ (cc, corpus callosum; str, striatum; lv, 
lateral ventricle) on sagittal sections obtained 
from  WT  (A1–C1)  and  Cdk2
/  (A2–C2) 
P90  mice  at  7  dpi.  Sections  are  stained 
with  anti-Ki67  or  anti-BrdU  and  a  marker 
specific for different ASVZ cell types: NG2 
(A1–2), Olig2 (B1–2), and Mash1 (C1–2). 
Broken  lines  delineate  the  ASVZ.  Arrow-
heads point to double-labeled cells. Cells in 
the boxed areas are represented with three-
fold magnification in the inset. Bar, 50 µm.   
(A3–C3)  Histograms  representing  the  num-
ber of proliferating cells of each type in the 
ASVZ in response to demyelination. Results 
are expressed as means ± SEM (error bars;   
*, P < 0.05; **, P < 0.001) and were ana-
lyzed by a t test.JCB • VOLUME 193 • NUMBER 2 • 2011   402
Figure 6.  Differentiation of oligodendrocytes in the 
absence of Cdk2. Immunolabeling of distinct stages 
of oligodendroglial maturation in demyelinated le-
sions of the CC on sagittal sections obtained from WT   
(A1–C1) and Cdk2
/ (A2–C2) P90 mice at 14 dpi. 
Olig2  (A1–2)  labels  the  overall  oligodendroglia, 
whereas CC1 (B1–2) is specific for postmitotic oligo-
dendrocytes, and NG2 (C1–2) identifies OPCs. Broken 
lines delineate the demyelinated lesion. Bar, 50 µm. 
(D–F) Histograms representing the number of differ-
ent oligodendroglial cells/mm
2 of demyelinated le-
sion at 7 (D), 14 (E), and 21 (F) dpi. Results are 
expressed as means ± SEM (error bars; *, P < 0.05; 
**, P < 0.001) and were analyzed by a t test.
Figure 5.  Oligodendrocyte proliferation in the LPC lesion. Characterization of proliferating cells in demyelinated lesions of the CC on sagittal sections 
obtained from WT (A1–D1) and Cdk2
/ (A2–D2) P90 mice after demyelination. Sections are stained with anti-Ki67 and a marker specific for different 
cell types: CD45 (A1–2) at 4 dpi, GFAP (B1–2), Olig2 (C1–2) at 7 dpi, and NG2 (D1–2) at 7 dpi and 14 dpi. Broken lines delineate the demyelinated 
lesion. Arrows point to double-labeled cells. Cells in the boxed areas are shown with threefold magnification in the insets. Bar, 50 µm. (A3–D3) Histograms 
representing the number of proliferating cells of each type in the demyelinated lesion. Results are expressed as means ± SEM (error bars; *, P < 0.05;   
**, P < 0.001) and were analyzed by a t test.403 Role of Cdk2 in OPC proliferation • Caillava et al.
not affect OPC cell cycle or the normal developmental process 
of myelination, it clearly alters adult OPC renewal and differ­
entiation under pathological conditions, leading to accelerated 
CNS remyelination.
We first analyzed Cdk2­deficient mice to elucidate the 
functional involvement of Cdk2 in OPC proliferation, oligo­
dendrogenesis, and developmental myelination in vivo. Loss 
of Cdk2 had no effect on OPC proliferation and generation of oligo­
dendrocytes during early postnatal (P8) development and in the 
adult (P90) CC. Moreover, differences in density and distribu­
tion of cells representing different stages of oligodendrocyte 
development were not observed in WT versus Cdk2
/ adult 
mice (P90), which suggests that Cdk2 is not required for normal 
development of myelinating oligodendrocytes in the postnatal 
and adult CNS. These data were confirmed by Western blot 
quantification of myelin in the early postnatal (P15) and adult 
axons in the lesion at 14 dpi; i.e., at a time corresponding to a 
high rate of OPC differentiation into oligodendrocytes (Fig. 8 A).   
We found a twofold increase in the percentage of myelinated 
axons in the lesion of Cdk2
/ mice, as compared with WT 
(Fig.  8,  B–D).  Moreover,  myelin  thickness,  as  assessed  by   
g ratio measurements, was also found to be significantly higher 
in the lesion of Cdk2
/ mice (Fig. 8 E). These differences 
were transient because electron microscopy analysis at 21 dpi 
confirmed that the delay of remyelination recovered with time 
in WT mice (Fig. 8, D and E), as suggested by immunohisto­
chemical analysis (Fig. 6 F). To eliminate the possibility that 
differences observed at 14 dpi reflected an alteration in axon 
density, we quantified the number of axons in the lesion and 
found that the total number of axons per lesion was identical 
between the two genotypes (WT, 224,700 ± 19,220 axons/mm
2; 
Cdk2
/,  261,500  ±  16,180  axons/mm
2;  P  =  0.15;  results 
were analyzed with a t test). Altogether, these data demonstrate 
that remyelination was accelerated in the absence of Cdk2 as 
a result of accelerated oligodendrocyte differentiation and de­
creased proliferation.
Discussion
The identification of extrinsic and intrinsic factors governing 
progenitor cell proliferation and differentiation in the postnatal   
brain is crucial to elucidate fundamental mechanisms of post­
natal neurogenesis and gliogenesis. Because adult OPCs and 
NPCs contribute to myelin repair, identification of these factors is   
also crucial to understanding endogenous remyelination, which 
in diseases such as multiple sclerosis is insufficient to ensure 
definitive recovery. Although our knowledge of extracellular 
signals that regulate OPC and NPC cell division is quite exten­
sive, the specific role of intrinsic regulators is less well defined.   
In the present study, we took advantage of a viable Cdk2
/ 
mutant mouse (Berthet et al., 2003) to investigate the functional 
role of this cell cycle regulator in NPC/OPC proliferation and 
differentiation in both normal postnatal/adult brain and after de­
myelination. We provide evidence that although Cdk2 loss does 
Figure 7.  Adult OPC differentiation in vitro. After 5 d   
in vitro, oligodendrocytes isolated from WT (A and C)   
and Cdk2
/ (B and D) P60 mice were immunostained 
with  anti-A2B5  (A  and  B)  and  anti-O4  (C  and  D).   
Bar, 100 µm. (E) Histogram representing the percentages 
of the different cell types. (F) Histogram representing the 
proportion of O4
+ cells according to their process num-
ber. Results are expressed as means ± SEM (error bars; 
*, P < 0.05; **, P < 0.001) and were analyzed by a 
t test.
Figure 8.  Remyelination 14 and 21 d after LPC injection. (A) Overview of 
a demyelinated lesion on a semithin section. Bar, 50 µm. (B and C) Images   
of  the  demyelinated  lesion  were  taken  by  electron  microscopy  from   
ultrathin sections of WT (B) and Cdk2
/ (C) P90 mice 14 dpi. Arrows 
point to demyelinated axons. Bar, 1 µm. (D) Histogram representing the 
percentage of myelinated axons compared with the total number of axons.   
(E) Histogram representing the g ratio in WT versus Cdk2
/ mice. Results 
are expressed as means ± SEM (error bars; *, P < 0.05; **, P < 0.001) 
and were analyzed by a t test.JCB • VOLUME 193 • NUMBER 2 • 2011   404
adult OPCs of Cdk2
/ mice, as compared with WT, as well as 
with enhanced differentiation of adult OPCs into differentiated 
CC1
+ oligodendrocytes. Interestingly, although NG2
+ OPC den­
sities were identical in the CC of WT and Cdk2
/ noninjured 
mice, their reduced proliferation at 7 dpi coincided with a re­
duction in OPC density in Cdk2
/ mice as compared with WT. 
In contrast, CC1
+ oligodendrocyte density increased in Cdk2
/ 
mice 1 and 2 wk later, a delay corresponding to the onset of   
remyelination and the oligodendrocyte/myelin regeneration 
period in LPC lesions, respectively. However, differences be­
tween Cdk2
/ mice and WT disappeared by 21 d, when the 
process of repair was nearly accomplished. Moreover, we dem­
onstrate that increased cell cycle exit and oligodendrocyte differ­
entiation in Cdk2
/ mice had a direct impact on the number of 
remyelinated axons, and on the extent of axonal remyelination, 
as assessed by g ratio measurements in the lesion. The fact that 
remyelination in WT mice leveled with that of Cdk2
/ mice at 
21 dpi further underlines the fact that Cdk2 acts as a modulator 
rather than as an on/off switch of the differentiation/remyelin­
ation process. These results are consistent with previous in vitro 
findings showing that Cdk2 loss decreased OPC proliferation 
(Belachew et al., 2002) and promoted lineage commitment of 
NG2­expressing progenitors in the adult SVZ, and differentia­
tion of adult neural progenitor cells (Jablonska et al., 2007). 
As the consequences of Cdk2 loss on adult OPC differentiation 
have not yet been described, this study highlights for the first 
time the role of Cdk2 as an intrinsic molecular mechanism that 
controls the timing of oligodendrocyte differentiation in vivo. 
This conclusion is supported by our findings that accelerated 
differentiation of oligodendroglial cells in the absence of Cdk2 
also occurred in vitro.
The role of Cdk2 in proliferation of adult hippocampal 
neural progenitors was also previously investigated. Interest­
ingly, in this progenitor population, Cdk2 did not appear to play 
a crucial role in cell proliferation, even after induction of sei­
zures (Vandenbosch et al., 2007). This discrepancy could be   
explained by compensatory mechanisms, which may be region­
specific and may reflect the low proliferative potential of hippo­
campal progenitors, as compared with their SVZ counterpart. 
Alternatively, these differences may have resulted from a non­
essential role played by Cdk2 in neurogenic regions of the brain, 
such as the adult hippocampus, as compared with the SVZ, which 
is directly involved in oligodendrogenesis, a process that more 
closely depends on the control of OPC proliferation by Cdk2.
In conclusion, the requirement for Cdk2 appears to be 
time, region, and cell specific. Despite the redundant function 
of Cdk2 in development, as demonstrated by the finding that 
Cdk2
/ mice are viable and display normal myelination, the 
present study reveals a crucial role for Cdk2 in adult OPC/NPC 
proliferation under pathological conditions. These findings could 
contribute to a better understanding of remyelination failure in 
multiple sclerosis. In this inflammatory disease, endogenous 
remyelination exists but is not efficient in all lesions. Among 
several possible hypotheses, dysregulation of OPC prolifera­
tion has been proposed to play a role in remyelination failure, 
as demonstrated by reduced OPC proliferation in some lesions, 
although in others OPCs are numerous, but appear unable to 
CC (P90) demonstrating similar levels of myelin protein ex­
pression in Cdk2
/ and WT mice. Finally, electron microscopy 
did not reveal changes in axonal preservation or in the number 
of myelinated axons, or differences in myelin structure, after 
Cdk2 loss in the postnatal (P15) or adult (P90) CC, as myelin 
compaction and g ratio did not significantly differ in Cdk2
/ 
and WT mice. Collectively, these data suggest that OPC prolif­
eration and oligodendrogenesis during early postnatal and adult 
stages are either Cdk2 independent or are efficiently compen­
sated by other Cdks.
Cdk1 could play this role, as unicellular organisms such 
as yeasts only require Cdk1 to drive cell division, and in the 
absence of interphase Cdks, Cdk1 can execute all the events that 
are required to drive mammalian cell division (Santamaría et al., 
2007). In p27
/;Cdk2
/ double KO mice, Cdk1 compensates 
the loss of Cdk2 function, binding to cyclin E and regulating 
G1/S transition (Berthet et al., 2003). As previously suggested, 
Cdk4 is also a strong candidate for functional compensation 
of Cdk2 (Jablonska et al., 2007), as both Cdk2 and Cdk4 are 
activated by their regulatory proteins cyclin E and D, respec­
tively, to sequentially phosphorylate Rb. Although Cdk2
/ or 
Cdk4
/ mice are viable, Cdk2
/;Cdk4
/ double KO mice die 
in utero around embryonic day 15 (E15; Berthet et al., 2006). 
Moreover, elevated levels of Cdk4 protein expression and activ­
ity were observed in Cdk2
/ tissue up to P15, before declining 
with comparable levels to WT mice (Jablonska et al., 2007). 
Consistent with this finding, proliferation and self­renewal of 
NPCs in the adult SVZ were indistinguishable in Cdk2
/ and 
WT mice up to P15 and then reduced in the adult (Jablonska   
et al., 2007). Therefore, the lack of significant differences in 
developmental myelination between Cdk2
/ and WT mice 
are likely to result from compensatory mechanisms occurring 
during CNS development.
Although OPCs are still produced in the adult from SVZ 
cells (Menn et al., 2006; Dimou et al., 2008; Rivers et al., 2008), 
decreased proliferation of these cells under physiological condi­
tions in the absence of Cdk2 (Jablonska et al., 2007; this study) 
seems sufficient to maintain a normal density of oligodendrog­
lial cells in the CC. However, when challenged with demyelin­
ation, a process known to enhance proliferation of resident adult 
OPCs and SVZ precursors (Nait­Oumesmar et al., 1999; Decker 
et al., 2002), we found that cell proliferation was reduced not 
only in the SVZ, but also in the lesion of Cdk2
/ mice. These 
alterations were not an indirect consequence of axonal loss, as 
no obvious alterations in axons and/or in axonal density were 
observed by electron microscopy. However, we cannot pres­
ently fully exclude the possibility that disruption of Cdk2 func­
tion could have enhanced cell recruitment to the lesion, thereby 
eliminating the need for self­renewal of local progenitors. This 
could have resulted in decreased OPC proliferation observed in 
the lesion of Cdk2
/ mice.
Because decreased proliferation specifically affected cells 
giving rise to oligodendrocytes, including OPCs and type C 
cells of the SVZ, rather than microglia and astrocytes, we in­
vestigated the consequences of altered proliferation on OPC 
differentiation into oligodendrocytes. We showed that reduced 
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Dako) diluted at 1:100 in carrier solution. Nuclei were counterstained with 
the nucleic acid stain Hoechst 33342 (Sigma-Aldrich) diluted at 1:1,000 
in PBS. Finally, tissue sections were washed in PBS and mounted under 
coverslips using Fluoromount (SouthernBiotech).
Immunohistochemistry for BrdU was performed treating sections 
for 30 min at 37°C with HCl 2 N in PBS containing 0.1% Triton X-100, 
then  rinsed  two  times  in  0.1  M  sodium  tetraborate  buffer,  pH  8.5.   
After several washes in PBS, sections were incubated overnight at 4°C   
with rat monoclonal anti-BrdU antibody (1:100; AbCys SA). For double   
labeling, sections were first immunostained with antibodies as just de-
scribed, then postfixed for 15 min in PFA 4% before BrdU pretreatment 
and labeling.
In vitro differentiation of adult OPC
Brains from 6 adult (P60) animals of each genotype were dissected and 
enzymatically digested using a solution containing 240 µg/ml l-cysteine, 
1.2 U/ml papain, and 40 µg/ml DNase (Sigma-Aldrich) at 37°C in a 
shaking water bath during 1 h. Tissue was then triturated with a Pasteur 
pipet and filtered through 40-µm mesh. Dissociated cells were layered on 
a performed Percoll gradient at 23,500 g for 20 min (GE Healthcare). 
The fraction containing glial progenitors and localized between the myelin 
and red blood cell fractions was then recovered. After washing, cells were 
resuspended in N1 (DME supplemented with insulin, transferrin, progester-
one, putrescine, and selenium; Invitrogen and Sigma-Aldrich), a serum-free 
medium mixed with B104 conditioned medium to increase the proportion 
of oligodendrocyte progenitors. Cells were plated in 4-well plates coated 
with polyornithine/laminin (Sigma-Aldrich) at 10
5 cells/well and kept at 
37°C in a humidified 9% CO2/air atmosphere.
Immunocytochemical  analysis  of  specific  cell  markers  was  per-
formed at 5 h and 5 d after plating.
Tissue processing for electron microscopy
Unlesioned animals were sacrificed for analysis at P15 or P90, and adult 
lesioned mice were sacrificed 14 and 21 d after LPC injection. Animals 
were intracardially perfused with 2% PFA and 2.5% glutaraldehyde (Elec-
tron Microscopy Sciences) in 0.1 M phosphate buffer. Lesioned brains 
were removed and cut into 100-µm free-floating vibratome sections (VT 
1000S; Leica). Slices were then postfixed with 2.5% glutaraldehyde for   
2 h and 2% osmium tetroxide (Electron Microscopy Sciences) for 30 min. After 
dehydration, slices were flat-embedded in epon. Ultrathin sections of the 
area of interest were cut using an ultramicrotome (Ultracut E; Reichert-Jung) 
and were analyzed using an electron microscope (CM 120; Philips).
Western blotting
Slices of 700 µm were cut out with a vibratome from P15 and P90 brains 
before the CC was carefully microdissected. Protein extraction was per-
formed using RIPA lysis buffer (50 mM Tris-HCl, pH 7.5, 1 mM EDTA,   
1 mM EGTA, 1 mM sodium orthovanadate, 50 mM sodium fluoride, 0.1% 
2-mercaptoethanol, 1% Triton X-100, and proteases inhibitor cocktail). Pro-
tein concentration was determined in each sample. Protein extracts were 
boiled for 5 min before loading onto 4–20% gradient gels (GeneMate; 
Bioexpress; 20 µg of protein per each lane). Gels were electrotrans-
ferred to a 0.2 µm nitrocellulose membrane (Millipore). Blots were blocked 
in 5% milk in TBST for 1 h, and then incubated at 4°C overnight with one 
of the following antibodies: anti-MBP (Covance) and anti-actin (Millipore). 
Bands were detected with appropriate horseradish peroxide–conjugated 
secondary  antibodies,  reacted  with  chemiluminescent  ECL  substrate   
(GE Healthcare), and visualized by exposure to x rays. Band intensity 
was measured using the ImageJ 1.39o software (National Institutes of   
Health). Western blots were obtained from the CC of 3–4 different ani-
mals in each group and age. Data were averaged and were represented 
as means ± SEM.
Quantification and statistical analyses
For quantitative data in unlesioned animals (4–5 animals/group), three 
sections were selected, 120 µm apart, with a starting point corresponding 
to the most rostral crossing of the CC. For each section, two to three fields 
were acquired in the medial part of the CC (5 µm thickness; step size = 
1 µm between successive images of the same field) with a 60× objective 
lens using a confocal system (Fluoview FV1000; Olympus) equipped with 
an  inverted  microscope  (IX81;  Olympus).  Corresponding  images  were 
quantified using the FV10-ASW software (Olympus) and cell counts were 
expressed as the number of cells per volume (10
4 µm
3) of CC. Statistical 
analysis was performed using unpaired two-tailed t test (Prism software, 
version 4.00; GraphPad Software Inc.).
fully differentiate (Chang et al., 2002). A previous study also 
demonstrated that persistent CNS inflammation significantly al­
tered cell kinetics of precursors and stem cells in experimental 
autoimmune encephalomyelitis, a model of multiple sclerosis 
(Pluchino et al., 2008). In view of the role of Cdk2 described 
here in adult NPCs/OPCs, altered proliferation or differentia­
tion of these cells in multiple sclerosis could be related to Cdk2 
dysregulation and could be, at least in part, responsible for the 
observed failure in remyelination. Thus, our study not only con­
tributes to a better understanding of NPC/OPC cell cycle control 
and expansion versus differentiation under normal physiologi­
cal conditions, but demonstrates a specific role of Cdk2 in re­
myelination, which may be crucial to design novel therapeutic 
approaches to promote CNS remyelination.
Materials and methods
Animals
Cdk2 mutant mice were generated by replacing exons 4 and 5 encoding 
the core kinase domain of Cdk2 with a PGK-neomycin cassette to function-
ally inactivate the Cdk2 gene (Berthet et al., 2003). This line was kept   
under a mixed background (C57BL/6 × 129S7/SvlmJ × CD1) as Cdk2 
heterozygotes because Cdk2
/ males and females are sterile. Early post-
natal (P8 and P15) or adult (P90) WT and Cdk2
/ littermates were used 
in all experiments. Mice were group-housed under standard conditions 
with food and water available ad libitum, and were maintained on a 12 h 
light/dark cycle. All animal protocols were performed in accordance with 
the guidelines published in the National Institutes of Health Guide for the 
Care and Use of Laboratory Animals.
Focal LPC-induced demyelination
As described previously (Nait-Oumesmar et al., 1999), five adult animals 
(P90) of each genotype were deeply anesthetized with 100 mg/kg body 
weight ketamine (Imalgene) and 10 mg/kg body weight xylazine (Rompun) 
dissolved in 0.9% sterile saline, and positioned in a stereotaxic frame.   
Animals were injected unilaterally into the CC, using appropriate coordi-
nates (1.5 mm anterior to the bregma, 1 mm lateral and 1.8 mm deep from 
the skull surface) with 2 µl of a 1% LPC solution (Sigma-Aldrich) in 0.9% 
NaCl. Animals were sacrificed 7, 14, and 21 d after LPC injection.
Cell proliferation
Cell proliferation was assessed by using Ki67 and/or BrdU immunostain-
ing. To assay proliferation in response to demyelination, at 7 d after LPC 
injection, two intraperitoneal injections of BrdU (60 mg/kg body weight; 
Sigma-Aldrich) were performed at 2-h intervals on the day of sacrifice.   
Animals were sacrificed at 2 h after the last BrdU injection.
Tissue processing for immunohistochemistry
P8, P15, and P90 animals were anesthetized with a lethal dose of ket-
amine (Imalgene) and intracardially perfused with 4% PFA in cold 0.1 M 
phosphate buffer (PBS, pH 7.4), and brains were postfixed in the same 
fixative for 1 h. Fixed tissues were then cryoprotected in 20% sucrose 
overnight at 4°C, and finally frozen at 60°C in isopentane cooled by 
liquid N2.
12-µm sagittal sections were cut with a cryostat (CM 3050S; Leica) 
and stored at 20°C for immunohistochemistry.
Immunohistochemistry
Sections were incubated at RT for 20 min in blocking solution (PBS containing 
0.1% Triton X-100 and 10% normal goat serum). Primary antibodies were di-
luted using the same carrier solution and incubated overnight at 4°C. Primary 
antibody dilutions were 1:100 for rabbit polyclonal anti-Olig2 (Millipore), 
rabbit polyclonal anti-NG2 (Abcys SA), mouse monoclonal anti-APC (clone 
CC1)  designated  here  as  anti-CC1  (EMD),  mouse  monoclonal  anti-MAG   
(Millipore), mouse monoclonal anti-CNPase (Millipore), mouse monoclonal 
anti-Mash1 (BD), mouse monoclonal anti-PSA-NCAM (AbCys SA), rabbit poly-
clonal anti-GFAP (Dako), rabbit polyclonal anti-MBP (Millipore), rat mono-
clonal anti-CD45 (Invitrogen), and mouse monoclonal anti-Ki67 (BD).
Sections were washed and incubated for 1 h with species-specific 
secondary antibodies conjugated to FITC or TRITC (SouthernBiotech or JCB • VOLUME 193 • NUMBER 2 • 2011   406
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For quantitative data in demyelinated animals (4–5 animals/group 
unless indicated), labeled cells were counted in the lesion previously identi-
fied by MBP immunolabeling. Cells were counted in the entire lesion area 
(two to four 12-µm sagittal sections through the CC), and results were ex-
pressed as number of cells per area of lesion (mm
2). In the anterior subven-
tricular zone (six 12-µm sagittal sections), results were expressed as the 
number of cells per surface (mm
2). Images were acquired with a 40× ob-
jective lens using a fluorescent microscope (DBM; Leica) and image acqui-
sition software (Explora Nova). Corresponding images were quantified 
using the ImageJ 1.39o software. Statistical analysis was performed using 
unpaired two-tailed t test (SigmaStat for Windows version 3.11; Systat 
Software Inc.).
For quantification by electron microscopy of P15 and P90 unlesioned 
brains or adult brains, 14 and 21 d after LPC injection (3–4 per group), 
15–20 electron microscope fields were randomly taken in the CC or in the 
lesion area at a magnification of 9,700. For unlesioned brain analysis, the 
numbers of total axons and myelinated axons were counted and expressed 
as a number of axons or myelinated axons per surface (mm
2). For lesioned 
brain analysis, the numbers of myelinated and unmyelinated axons in the 
lesion were counted. The percentage of myelinated axons was expressed 
as the percentage of the total number of axons in the lesion, and the total 
number of axons in the lesion was expressed as a number of axons per 
surface (mm
2). The g ratio in nonlesioned CC and in the lesion was ob-
tained by dividing axon circumference by axon plus myelin sheath circum-
ference measured using the ImageJ 1.39o software at a magnification of 
33,000 magnification. Statistical analysis was performed using unpaired 
two-tailed t test (SigmaStat).
Evaluation of cell death with TUNEL assay
Apoptotic nuclei were labeled in situ by the TUNEL method (Promega). Fro-
zen sections of fixed tissue were brought to RT, rinsed for 5 min in PBS 
twice, and treated with 20 µg/ml proteinase K for 10 min at RT to permea-
bilize tissues to the staining reagents. After a 5-min rinse in PBS, sections 
were fixed for 5 min with PFA 4% at RT. After PBS rinsing, sections were 
preincubated in equilibration buffer (25 mM Tris-HCl, pH 6.6, containing 
200 mM potassium cacodylate and 2.5 mM cobalt chloride). Sections 
were then drop-incubated in TdT incubation buffer (containing rTdT en-
zyme and 5 µM fluorescein-12-dUTP) in a humidified chamber for 60 min 
at 37°C. The reaction was stopped by a 15-min immersion in 2× SSC 
buffer (300 mM NaCl and 30 mM sodium citrate). Sections were rinsed 
three times in PBS to remove unincorporated fluorescein-12-dUTP. As de-
scribed previously, nuclei were counterstained with Hoechst 33342 (Sigma- 
Aldrich), and tissue sections were mounted under coverslips using Fluoro-
mount (SouthernBiotech).
Online supplemental material
Fig. S1 shows that there is no difference comparing oligodendroglial lin-
eage in the CC area from WT and Cdk2
/ mice. Fig. S2 shows that there 
is no difference comparing OPC proliferation and myelination from WT 
and Cdk2
/ P90 mice. Fig. S3 shows that cell proliferation assessed by 
BrdU  in  response  to  demyelination  in  the  adult  brain  is  decreased  in 
Cdk2
/ mice compared with WT mice. Fig. S4 shows that there is no   
difference in apoptosis in response to demyelination comparing WT   
and Cdk2
/ P90 mice. Fig. S5 shows that proliferation of GFAP
+ and 
PSA-NCAM
+ cells from the adult ASVZ is not affected by the loss of Cdk2 
in response to demyelination. Online supplemental material is available at 
http://www.jcb.org/cgi/content/full/jcb.201004146/DC1.
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